© 2024 Intra-Cellular Therapies Inc. All rights reserved.
SEC Filings
| Filing date | Form | Description | View |
|---|---|---|---|
| 5 | Annual filing director officer or owner of more than ten percent. |
View HTML | |
| SC 13G/A | An amendment to the SC 13G filing |
View HTML | |
| 8-K | Report of unscheduled material events or corporate event |
View HTML | |
| 424B3 | Form of prospectus reflecting facts events constituting substantive change from last form |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 424B1 | Form of prospectus that discloses information previously omitted from the prospectus |
View HTML | |
| S-1MEF | Registration of up to an additional 20% of securities for any offering registered on an S-1 |
View HTML | |
| EFFECT | EFFECT |
View HTML | |
| CERTNAS | CERTNAS |
View HTML | |
| S-1/A | Amended Registration statement for face-amount certificate companies |
View HTML |
Data provided by Kaleidoscope.